GoBroad Healthcare Group and XtalPi Sign Strategic Partnership to Advance AI-Powered Laboratory Automation

GoBroad Healthcare Group (GHG) recently signed a strategic cooperation agreement with XtalPi to explore the integration of artificial intelligence (AI) into clinical laboratory workflows. The partnership will initially focus on the joint development of an AI-powered automated flow cytometry analysis platform, combining GoBroad's expertise and clinical resources in patient care, clinical research, and translational medicine with XtalPi's capabilities in AI algorithms and laboratory automation. The collaboration aims to advance the standardization and intelligent automation of clinical laboratories.

Addressing Clinical Challenges Through AI-Powered Flow Cytometry

Flow cytometry plays an essential role in immunophenotyping, disease assessment, and clinical research in hematologic disorders. Conventional multicolor flow cytometry analysis involves complex procedures, including fluorescence compensation, cell population identification, and sequential manual gating. These processes rely heavily on specialist expertise, leaving opportunities to improve analytical efficiency and consistency.

To address these challenges, XtalPi has developed a prototype of its core AI algorithms for flow cytometry analysis, which is currently undergoing validation. Building on this foundation, the two organizations will focus their joint development efforts on four key areas: automated fluorescence compensation, AI-assisted gating and cell population classification, end-to-end automated analysis, and structured report generation. Together, these capabilities are intended to support the development of a more efficient and standardized automated analysis platform.

Combining Clinical Expertise and Technology to Advance Innovation

GoBroad has extensive experience in the diagnosis and treatment of hematologic disorders and immunotherapy, supported by its clinical resources and multicenter research capabilities. Guided by real-world clinical needs, the collaboration will incorporate expert interpretation and clinical research scenarios into ongoing algorithm optimization and clinical validation, with particular emphasis on improving the applicability and reliability of AI models in complex samples and challenging disease classifications.

Looking ahead, the proposed platform aims to integrate AI algorithms with laboratory automation technologies to streamline flow cytometry workflows, reduce repetitive manual operations, and improve analytical efficiency and consistency.

Exploring Clinically Driven Innovation Through Medical–Technology Collaboration

This strategic partnership represents a joint effort to combine clinical expertise with advanced technology and accelerate the translation of technological innovation into practical medical applications. GoBroad and XtalPi will continue to collaborate on technology development, clinical validation, and the translation of research outcomes into practical solutions, exploring scalable AI-assisted laboratory analysis technologies.

The collaboration aims to support advances in hematologic disease diagnostics, improve clinical research efficiency, and facilitate the translation of innovative drug development into clinical applications, ultimately contributing to better patient care.